A PROSPECTIVE STUDY ON CLINICOEPIDEMIOLOGICAL PROFILE OF MOLAR PREGNANCY IN A TERTIARY CARE HOSPITAL

Authors

  • Dr. Ajit Kumar Nayak M.D., DNB(O & G),FICOG, PG DMCH,DIP in USG, Associate Professor, Department of Obstetrics & Gynaecology, Fakir Mohan Govt. Medical College, Balasore, Odisha
  • Dr. Sumitra Hota 3rd year PG, Department of Obstetrics & Gynaecology, SCB Medical College & Hospital, Cuttack, Odisha
  • Dr. Maya Padhi M.D. (O& G), Professor, Department of Obstetrics & Gynaecology, SCB Medical College & Hospital, Cuttack, Odisha
  • , Dr. Manju Kumari Jain MBBS, DGO, DNB (O & G), DMCH, DIP in USG, SMO, Department of Transfusion Medicine, SCB Medical College & Hospital, Cuttack, Odisha

DOI:

https://doi.org/10.32553/ijmbs.v3i9.552

Keywords:

Beta hCG, Chemotherapy, Gestational trophoblastic disease, Hydatidiform mole, molar pregnancy

Abstract

Introduction: Gestational trophoblastic diseases (GTD) refers to a spectrum of pregnancy related trophoblastic abnormalities. The objective of this study was to determine the incidence of molar pregnancies in SCB Medical College & Hospital along with the demographics and risk factors associated and to evaluate its management and outcome.

 Methods: The study was a prospective epidemiological study which includes fifty eight patients with gestational trophobastic diseases treated at the gynecological ward, S.C.B. Medical College & Hospital, Cuttack, Odisha during July 2015 to July 2017.

Results: The incidence was 2.85 in 1000 deliveries in the institution. Most of the patients belonged to low socioeconomic status and in the age group of 21 to 30 years. Primigravida were more prone to the disease and no patients had history of molar in prior pregnancies. Most commonly encountered symptom was vaginal bleeding following a period of amenorrhea. Second trimester was the most common time of presentation with mean gestational age around 12 weeks. Out of 57 patients treated with suction and evacuation, 23 patients developed persistent trophoblastic disease who were further managed by methotrexate and folinic acid. Failure rate of single agent chemotherapy was 21.7% which were successfully managed by triple agent chemotherapy [EMA-CO regimen].

Conclusion: Incidence of molar pregnancies in this study was much higher as this hospital is the referral centre for South Eastern Odisha. However, proper reporting and follow up can prevent mortality associated with malignant transformation.

Keywords: Beta hCG, Chemotherapy, Gestational trophoblastic disease, Hydatidiform mole, molar pregnancy

Downloads

Published

2019-09-22

How to Cite

Nayak, D. A. K., Hota, D. S., Padhi, D. M., & Jain, , D. M. K. (2019). A PROSPECTIVE STUDY ON CLINICOEPIDEMIOLOGICAL PROFILE OF MOLAR PREGNANCY IN A TERTIARY CARE HOSPITAL. International Journal of Medical and Biomedical Studies, 3(9), 146–152. https://doi.org/10.32553/ijmbs.v3i9.552

Issue

Section

Research Articles